ReviewJournal of clinical medicine2023

Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug.

Anna Maria Dąbrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.